PROTEOMIC ANALYSIS OF ACTIVE MULTIPLE SCLEROSIS LESIONS
摘要
The invention provides methods for treating demyelinating inflammatory diseases by administering to the subject an effective amount of an agent that provides activated protein C activity, where the dose is effective to reduce the adverse clinical indicia of the disease. In some embodiments, the patient being treating is of the chronic active plaque type.
申请公布号
WO2009099642(A3)
申请公布日期
2010.01.14
申请号
WO2009US00760
申请日期
2009.02.05
申请人
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY;STEINMAN, LAWRENCE;HAN, MAY, H.